- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02748070
Perioperative Oral Steroids for Chronic Rhinosinusitis Without Polyps (CRSsNP)
July 23, 2020 updated by: Julia Noel, Stanford University
The Role of Perioperative Systemic Steroids in Patients With Chronic Rhinosinusitis Without Polyps (CRSsNP)
While oral steroids have been shown to be effective in the management of patients with chronic rhinosinusitis with polyps, its role in treating chronic rhinosinusitis without polyps (CRSsNP) is ambiguous.
Despite a lack of strong clinical evidence to suggest a benefit in this disease state, steroids are often prescribed as a component of post-operative care after sinus surgery for patients without polyps.
Oral steroids carry with them significant adverse effects, and should be prescribed thoughtfully.
The aims of this study are to determine if oral steroids in the peri-operative period improves patient outcomes in CRS without polyps.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
81
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- CRSsNP as defined by Clinical Practice Guideline (Update) on Adult Sinusitis
- scheduled to undergo endoscopic sinus surgery
Exclusion Criteria:
- chronic rhinosinusitis with polyps (CRSwNP)
- Aspirin exacerbated respiratory disease
- Cystic fibrosis
- Immunosuppressive states (Human immunodeficiency virus, transplant)
- Oral steroid use within 30 days of surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Prednisone
Provided oral steroid and topical steroid
|
|
Placebo Comparator: Placebo
Provided oral placebo and topical steroid
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sino-nasal Outcome Test (SNOT-22) Over Time
Time Frame: Baseline, 1, week, 1 month, 3 months, and 6 months
|
SNOT-22 is a validated scale which measures sinonasal symptoms for sinusitis patients.
The 22 questions are rated on a scale of 0-5 for a maximum total score of 110.
Higher scores represent more symptomatic patients.
|
Baseline, 1, week, 1 month, 3 months, and 6 months
|
Lund Kennedy Endoscopy Score Over Time
Time Frame: Baseline, 1, week, 1 month, 3 months, and 6 months
|
The Lund-Kennedy score is a validated scale by which clinicians grade the endoscopic appearance of the sinonasal cavity for sinusitis patients.
There are 5 parameters rated on a scale of 0-2 for each side of the nose, for a maximum total score of 20 points.
Higher scores represent a worse endoscopic appearance.
|
Baseline, 1, week, 1 month, 3 months, and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Julia E Noel, MD, Stanford University
- Principal Investigator: Michael T Chang, MD, Stanford University
- Principal Investigator: Peter H Hwang, MD, Stanford University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2015
Primary Completion (Actual)
July 15, 2019
Study Completion (Actual)
July 15, 2019
Study Registration Dates
First Submitted
April 15, 2016
First Submitted That Met QC Criteria
April 19, 2016
First Posted (Estimate)
April 22, 2016
Study Record Updates
Last Update Posted (Actual)
August 4, 2020
Last Update Submitted That Met QC Criteria
July 23, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Otorhinolaryngologic Diseases
- Pathological Conditions, Anatomical
- Paranasal Sinus Diseases
- Nose Diseases
- Sinusitis
- Polyps
- Physiological Effects of Drugs
- Autonomic Agents
- Peripheral Nervous System Agents
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Antineoplastic Agents, Hormonal
- Dermatologic Agents
- Bronchodilator Agents
- Anti-Asthmatic Agents
- Respiratory System Agents
- Anti-Allergic Agents
- Prednisone
- Fluticasone
Other Study ID Numbers
- 33096
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Rhinosinusitis
-
Unity Health TorontoCompletedChronic RhinosinusitisCanada
-
University of MiamiCompleted
-
Medtronic Surgical TechnologiesCompleted
-
University of MichiganNeilMed PharmaceuticalsCompletedChronic RhinosinusitisUnited States
-
Odense University HospitalCompleted
-
Taichung Veterans General HospitalCompletedPostoperative Care | Chronic RhinosinusitisTaiwan
-
Christiane HaaseActive, not recruitingAsthma | Chronic Rhinosinusitis (Diagnosis) | Chronic Rhinosinusitis With Nasal Polyps | Chronic Rhinosinusitis Without Nasal PolypsDenmark
-
Washington University School of MedicineCompletedChronic Rhinosinusitis (Diagnosis) | Allergic Rhinosinusitis | Chronic Eosinophilic RhinosinusitisUnited States
-
Johns Hopkins UniversityGlaxoSmithKlineRecruitingChronic Rhinosinusitis (Diagnosis) | Chronic Rhinosinusitis With Nasal PolypsUnited States
Clinical Trials on Prednisone
-
Merck KGaA, Darmstadt, GermanyCompleted
-
University of South FloridaNational Heart, Lung, and Blood Institute (NHLBI); National Institute of Arthritis... and other collaboratorsActive, not recruitingVasculitis | Granulomatosis With Polyangiitis | Wegener GranulomatosisUnited States
-
Rabin Medical CenterUnknown
-
University of Alabama at BirminghamNational Institute of Neurological Disorders and Stroke (NINDS)CompletedMyasthenia GravisThailand, Canada, Germany, Italy, Netherlands, Brazil, United States, Argentina, Australia, Chile, Japan, Mexico, Poland, Portugal, South Africa, Spain, Taiwan, United Kingdom
-
Fundación Pública Andaluza para la Investigación...Sociedad Andaluza de Trasplantes de Organos y TejidosCompletedRenal Transplant Rejection | Other Complication of Kidney TransplantSpain
-
Prof. Tony hayek MDCompletedDiabetes | Atherosclerosis | DyslipidemiasIsrael
-
Health Science Center of Xi'an Jiaotong UniversityUnknownFocal Segmental GlomerulosclerosisChina
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI); National Institute of Arthritis... and other collaboratorsActive, not recruitingGranulomatosis With PolyangiitisUnited States, Canada
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloUnknown
-
National Institute for Tuberculosis and Lung Diseases...SuspendedInterstitial Lung Disease | Lung Neoplasm MalignantPoland